EntryPoint Capital LLC Takes Position in Privia Health Group, Inc. (NASDAQ:PRVA)

EntryPoint Capital LLC acquired a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 21,366 shares of the company's stock, valued at approximately $418,000.

A number of other hedge funds have also made changes to their positions in the business. FMR LLC increased its stake in Privia Health Group by 1.5% in the third quarter. FMR LLC now owns 18,169,043 shares of the company's stock valued at $330,858,000 after purchasing an additional 271,645 shares during the last quarter. Riverbridge Partners LLC boosted its holdings in shares of Privia Health Group by 19.7% in the fourth quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company's stock valued at $113,868,000 after acquiring an additional 958,418 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Privia Health Group by 1.0% in the third quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company's stock valued at $43,986,000 after purchasing an additional 23,178 shares during the period. Franklin Resources Inc. increased its position in shares of Privia Health Group by 2.2% in the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company's stock valued at $23,092,000 after buying an additional 28,480 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Privia Health Group by 6.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,133,873 shares of the company's stock worth $22,167,000 after buying an additional 69,649 shares during the last quarter. Hedge funds and other institutional investors own 94.48% of the company's stock.

Remove Ads

Privia Health Group Stock Performance

Shares of PRVA stock traded down $0.33 during mid-day trading on Friday, hitting $22.59. 757,835 shares of the stock traded hands, compared to its average volume of 773,534. The firm has a market cap of $2.72 billion, a price-to-earnings ratio of 225.92, a price-to-earnings-growth ratio of 3.47 and a beta of 0.85. The company's 50-day simple moving average is $23.80 and its 200-day simple moving average is $21.18. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $26.04.

Analyst Upgrades and Downgrades

PRVA has been the subject of several recent research reports. Canaccord Genuity Group raised their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a report on Friday, February 28th. Needham & Company LLC reissued a "buy" rating and set a $30.00 price objective on shares of Privia Health Group in a research note on Friday, March 21st. Macquarie initiated coverage on Privia Health Group in a research note on Monday, December 16th. They issued an "outperform" rating and a $25.00 target price on the stock. Piper Sandler raised their price target on Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a research report on Friday, February 28th. Finally, JMP Securities set a $29.00 price objective on Privia Health Group in a research report on Friday, February 28th. One research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus price target of $26.67.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.